Tag: Cancer Vaccine Center, Dana-Farber Cancer Institute
-
Health
Study finds promise in combined transplant/vaccine therapy for high-risk leukemia
Two of the most powerful approaches to cancer treatment — a stem cell transplant and an immune system-stimulating vaccine — appear to reinforce each other in patients with an aggressive, hard-to-control form of leukemia, Harvard scientists at Dana-Farber Cancer Institute (DFCI) have found. The researchers report that patients with high-risk acute myeloid leukemia (AML) or…
-
Science & Tech
Scientists may have identified new target for HIV vaccine
By coaxing the HIV-1 protein to reveal a hidden portion of its protein coat, scientists at Dana-Farber Cancer Institute and Harvard Medical School have provided a newly detailed picture of how protective, or so-called broadly neutralizing, antibodies block HIV-1 infection. In a study in the January issue of Immunity, the investigators report that the discovery…